The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(1H-indol-4-yl)-6-(1-methyl-1H-pyrazol-5-yl)-4-(4-(methylsulfonyl)piperazin-1-yl)quinazoline ID: ALA5194672
PubChem CID: 168287109
Max Phase: Preclinical
Molecular Formula: C25H25N7O2S
Molecular Weight: 487.59
Associated Items:
Names and Identifiers Canonical SMILES: Cn1nccc1-c1ccc2nc(-c3cccc4[nH]ccc34)nc(N3CCN(S(C)(=O)=O)CC3)c2c1
Standard InChI: InChI=1S/C25H25N7O2S/c1-30-23(9-11-27-30)17-6-7-22-20(16-17)25(31-12-14-32(15-13-31)35(2,33)34)29-24(28-22)19-4-3-5-21-18(19)8-10-26-21/h3-11,16,26H,12-15H2,1-2H3
Standard InChI Key: WNRKOKLVNNNTGY-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
2.4897 1.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6612 0.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4816 0.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8172 1.6612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2041 2.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2041 3.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4897 3.4508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7752 3.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7752 2.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0607 1.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0607 0.9758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 0.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 -0.2616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0607 -0.6741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0607 -1.4991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 -1.9116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 -2.7366 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0607 -3.1491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3681 -1.4991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3681 -0.6741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3681 0.9758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0826 0.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7970 0.9758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5115 0.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5977 -0.2571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9846 -0.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4047 -0.4286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8172 0.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2652 0.8988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7970 1.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0826 2.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3681 1.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 2.2133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4804 -2.7366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0671 -3.4508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
4 3 1 0
5 4 1 0
1 5 2 0
5 6 1 0
7 6 2 0
8 7 1 0
1 9 1 0
9 8 2 0
9 10 1 0
10 11 1 0
11 12 2 0
13 12 1 0
13 14 1 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 16 1 0
20 19 1 0
13 20 1 0
21 12 1 0
21 22 1 0
22 23 2 0
24 23 1 0
25 24 1 0
26 25 1 0
25 27 1 0
27 28 2 0
28 29 1 0
29 24 2 0
23 30 1 0
30 31 2 0
32 31 1 0
21 32 2 0
32 33 1 0
33 10 2 0
17 34 2 0
17 35 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 487.59Molecular Weight (Monoisotopic): 487.1790AlogP: 3.26#Rotatable Bonds: 4Polar Surface Area: 100.01Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.58CX LogP: 3.38CX LogD: 3.38Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.42Np Likeness Score: -1.61
References 1. Bin H, Chen P, Wu M, Wang F, Lin G, Pan S, Liu J, Mu B, Nan J, Huang Q, Li L, Yang S.. (2022) Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo., 232 [PMID:35183872 ] [10.1016/j.ejmech.2022.114187 ]